Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
35,871,067
-
Share change
-
+545,189
-
Total reported value
-
$243,568,283
-
Put/Call ratio
-
42591%
-
Price per share
-
$6.79
-
Number of holders
-
117
-
Value change
-
+$2,668,124
-
Number of buys
-
56
-
Number of sells
-
48
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q4 2024
As of 31 Dec 2024,
Pulmonx Corp - COM (LUNG) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,871,067 shares.
The largest 10 holders included
FMR LLC, PRIMECAP MANAGEMENT CO/CA/, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BNP PARIBAS ASSET MANAGEMENT Holding S.A., DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, and Altium Capital Management LLC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.